Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study

Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anlong Jiang, Le Wang, Justin Y. D. Lu, Amy Freeman, Charlie Campbell, Ping Su, Albert H. C. Wong, Fang Liu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d31ac84f8ca48baabd3a110d5c4cedf
record_format dspace
spelling oai:doaj.org-article:4d31ac84f8ca48baabd3a110d5c4cedf2021-11-25T16:56:33ZSex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study10.3390/brainsci111113982076-3425https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3425/11/11/1398https://doaj.org/toc/2076-3425Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manifests differently in males and females, including abnormalities in the dopamine system that are also seen in <i>Fmr1</i>-knockout (KO) mice. We investigated sex differences in dopamine signaling in <i>Fmr1</i>-KO mice in response to L-stepholidine, a dopamine D1 receptor agonist and D2 receptor antagonist. We found significant sex differences in basal levels of phosphorylated protein kinase A (p-PKA) and glycogen synthase kinase (GSK)-3β in wild type mice that were absent in <i>Fmr1</i>-KO mice. In wild-type mice, L-stepholidine increased p-PKA in males but not female mice, decreased p-GSK-3 in female mice and increased p-GSK-3 in male mice. Conversely, in <i>Fmr1</i>-KO mice, L-stepholidine increased p-PKA and p-GSK-3β in females, and decreased p-PKA and p-GSK-3β in males.Anlong JiangLe WangJustin Y. D. LuAmy FreemanCharlie CampbellPing SuAlbert H. C. WongFang LiuMDPI AGarticleFragile X syndromesex differenceL-stepholidinedopamine signaling<i>Fmr1</i> knockoutD1 receptorNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain Sciences, Vol 11, Iss 1398, p 1398 (2021)
institution DOAJ
collection DOAJ
language EN
topic Fragile X syndrome
sex difference
L-stepholidine
dopamine signaling
<i>Fmr1</i> knockout
D1 receptor
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Fragile X syndrome
sex difference
L-stepholidine
dopamine signaling
<i>Fmr1</i> knockout
D1 receptor
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Anlong Jiang
Le Wang
Justin Y. D. Lu
Amy Freeman
Charlie Campbell
Ping Su
Albert H. C. Wong
Fang Liu
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
description Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manifests differently in males and females, including abnormalities in the dopamine system that are also seen in <i>Fmr1</i>-knockout (KO) mice. We investigated sex differences in dopamine signaling in <i>Fmr1</i>-KO mice in response to L-stepholidine, a dopamine D1 receptor agonist and D2 receptor antagonist. We found significant sex differences in basal levels of phosphorylated protein kinase A (p-PKA) and glycogen synthase kinase (GSK)-3β in wild type mice that were absent in <i>Fmr1</i>-KO mice. In wild-type mice, L-stepholidine increased p-PKA in males but not female mice, decreased p-GSK-3 in female mice and increased p-GSK-3 in male mice. Conversely, in <i>Fmr1</i>-KO mice, L-stepholidine increased p-PKA and p-GSK-3β in females, and decreased p-PKA and p-GSK-3β in males.
format article
author Anlong Jiang
Le Wang
Justin Y. D. Lu
Amy Freeman
Charlie Campbell
Ping Su
Albert H. C. Wong
Fang Liu
author_facet Anlong Jiang
Le Wang
Justin Y. D. Lu
Amy Freeman
Charlie Campbell
Ping Su
Albert H. C. Wong
Fang Liu
author_sort Anlong Jiang
title Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
title_short Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
title_full Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
title_fullStr Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
title_full_unstemmed Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
title_sort sex differences in dopamine receptor signaling in <i>fmr1</i> knockout mice: a pilot study
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf
work_keys_str_mv AT anlongjiang sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT lewang sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT justinydlu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT amyfreeman sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT charliecampbell sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT pingsu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT alberthcwong sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
AT fangliu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy
_version_ 1718412834876948480